Verifying Clearance...
FDA Panel Endorses Revolutionary mRNA Flu Vaccine for Seniors
The FDA advisory panel has unanimously recommended Moderna's mRNA-based flu vaccine, marking a significant shift in vaccine development for older adults, a vulnerable demographic amid seasonal flu outbreaks.
This story is using an image pulled from the original reporting.
READ NEXT
Recommended Intelligence
Looking for the best next stories...
No comments yet. Start the conversation.